Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 May 2011

Paik Paul K, Arcila Maria E, Fara Michael, Sima Camelia S, Miller Vincent A, Kris Mark G, Ladanyi Marc, Riely Gregory J

Abstract excerpt

PURPOSE: BRAF mutations occur in non-small-cell lung cancer. Therapies targeting BRAF mutant tumors have recently been identified. We undertook this study to determine the clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. PATIENTS AND METHODS: We reviewed data from consecutive patients with lung adenocarcinoma whose tumors underwent BRAF, EGFR, and KRAS mutation testing as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, ras
Share to Adenocarcinoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Adenocarcinoma of Lung

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Oncogene Proteins, Fusion

Share to Proto-Oncogene Proteins B-raf

Share to Smoking

Source

Open in PubMed Open full text

Identifiers

PMID: 21483012
DOI: 10.1200/JCO.2010.33.1280
PMCID: PMC3107760

Genes

BRAF
ALK
EGFR
KRAS

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.PMID 21483012Read ↗

Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.Semantic proximity Read ↗

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.Semantic proximity Read ↗

Clinical characteristics and course of 63 patients with BRAF mutant lung cancers.Semantic proximity Read ↗

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.Semantic proximity Read ↗

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation.Semantic proximity Read ↗

Unveiling BRAF Mutations in Non-small Cell Lung Cancer: State of the Art and Future Perspectives.Semantic proximity Read ↗

Prevalence and Clinicopathological Characteristics of BRAF Mutations in Chinese Patients with Lung Adenocarcinoma.Semantic proximity Read ↗

Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.Semantic proximity Read ↗

Pathways and targeting avenues of BRAF in non-small cell lung cancer.Semantic proximity Read ↗

BRAF-mutations in non-small cell lung cancer.Semantic proximity Read ↗

Advances in anti-BRAF therapies for lung cancer.Semantic proximity Read ↗

Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.